We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.92%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$43.9B
AUM Growth
+$2.87B
(+7%)
Cap. Flow
-$890M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
13.25%
Holding
2,343
New
170
Increased
997
Reduced
1,015
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$111M |
| 2 |
Verizon
VZ
|
+$103M |
| 3 |
AT&T
T
|
+$103M |
| 4 |
Kroger
KR
|
+$97.1M |
| 5 |
3M
MMM
|
+$92.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$138M |
| 2 |
Tesla
TSLA
|
+$110M |
| 3 |
JPMorgan Chase
JPM
|
+$103M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$89.4M |
| 5 |
Apple
AAPL
|
+$85.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 16.25% |
| 3 | Financials | 11.85% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Fortinet
FTNT
$118B
| $16.5M | 0.04% |
338,972
-313,994
| -48% | -$16.4M |
|
527
RingCentral
RNG
$5.27B
| $16.5M | 0.04% |
469,753
-329,380
| -41% | -$11.8M |
|
528
Constellation Energy
CEG
$98.5B
| $16.5M | 0.04% |
191,724
+98,890
| +107% | +$8.9M |
|
529
Idacorp
IDA
$8.14B
| $16.4M | 0.04% |
152,246
-32,921
| -18% | -$3.41M |
|
530
Berkshire Hathaway Class A
BRK.A
$1.11T
| $16.4M | 0.04% |
35
| – | – |
|
|
FLG
531
Flagstar Bank National Association
FLG
$5.89B
| $16.3M | 0.04% |
629,956
+160,057
| +34% | +$4.29M |
|
532
BWX Technologies
BWXT
$15.6B
| $16.1M | 0.04% |
280,191
-19,497
| -7% | -$1.12M |
|
533
Donaldson
DCI
$11.3B
| $15.9M | 0.04% |
269,658
-59,205
| -18% | -$3.39M |
|
534
NetApp
NTAP
$38.5B
| $15.9M | 0.04% |
265,710
+131,524
| +98% | +$8.72M |
|
535
Gen Digital
GEN
$17.5B
| $15.8M | 0.04% |
748,971
-1,239,789
| -62% | -$27.4M |
|
536
Euronet Worldwide
EEFT
$2.67B
| $15.6M | 0.04% |
165,521
+11,186
| +7% | +$968K |
|
537
ZTO Express
ZTO
$17.6B
| $15.6M | 0.04% |
580,792
-82,325
| -12% | -$1.89M |
|
538
Hertz
HTZ
$937M
| $15.6M | 0.04% |
1,029,450
+369,147
| +56% | +$6.22M |
|
539
Graham Holdings Company
GHC
$4.97B
| $15.5M | 0.04% |
26,180
+2,124
| +9% | +$1.3M |
|
540
Black Hills Corp
BKH
$5.63B
| $15.5M | 0.04% |
220,700
+53,845
| +32% | +$3.62M |
|
541
American Financial Group
AFG
$12B
| $15.5M | 0.04% |
112,635
+819
| +0.7% | +$112K |
|
542
Thor Industries
THO
$4.23B
| $15.3M | 0.03% |
204,730
-24,955
| -11% | -$2.01M |
|
543
Hawaiian Electric Industries
HE
$2.06B
| $15.3M | 0.03% |
366,080
-55,765
| -13% | -$2.15M |
|
544
ADT
ADT
$5.52B
| $15.3M | 0.03% |
1,687,891
+675,441
| +67% | +$6.01M |
|
545
Manhattan Associates
MANH
$11.4B
| $15.3M | 0.03% |
127,538
-16,984
| -12% | -$2.09M |
|
|
WWE
546
DELISTED
World Wrestling Entertainment
WWE
| $15.2M | 0.03% |
224,170
+88,035
| +65% | +$6.65M |
|
547
Credicorp
BAP
$29.9B
| $15.2M | 0.03% |
112,271
-1,533
| -1% | -$217K |
|
548
Ziff Davis
ZD
$1.98B
| $15.2M | 0.03% |
194,929
-89,585
| -31% | -$7.21M |
|
549
Xerox
XRX
$424M
| $15M | 0.03% |
1,042,166
+431,129
| +71% | +$6.5M |
|
550
Bank OZK
OZK
$5.67B
| $15M | 0.03% |
373,722
-158,018
| -30% | -$6.78M |
|
Similar funds
VGA
AQR Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, AQR Capital Management held 2,343 positions worth $43.9B, up 7% from $41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2022 filing shows 170 new, 997 increased, 1,015 reduced and 150 closed positions. Its largest new stake was Generac Holdings: 310,080 shares worth $30.5M. The largest sale was Gilead Sciences, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q4 2022 buy was Generac Holdings: 310,080 shares worth $30.5M.
- AQR Capital Management added most to Humana in Q4 2022, an estimated $111M increase.
- AQR Capital Management's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $138M.
- AQR Capital Management fully exited Abiomed Inc in Q4 2022, selling an estimated $22.4M.
- AQR Capital Management's ten largest holdings make up 13% of its $43.9B portfolio in Q4 2022.
- AQR Capital Management opened 170 new positions and closed 150 in Q4 2022.
- AQR Capital Management's portfolio value rose 7% quarter-over-quarter to $43.9B.
Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.